Office Ladies
An Interview with Kathy Bates
Jenna Fischer
Herceptin. Yeah, it's a targeted immunotherapy. I mean, really, it's only been out for about 25 years. And it has just drastically changed the prognosis for women with HER2 positive breast cancers.
0
💬
0
Comments
Log in to comment.
There are no comments yet.